lunes, 26 de mayo de 2025

Determining the Risk of Recurrence in HR+/HER2- Early Breast Cancer Without Axillary Dissection Authors: Sara M. Tolaney, MD, MPH; Elizabeth A. Mittendorf, MD, PhD, MHCM; Leah H. Portnow, MD

https://www.medscape.org/viewarticle/1002279?sso=true&uac=148436CN&src=mkmcmr_driv_stan_mscpedu_250526-OUS-HONC-1002279-cta

No hay comentarios:

Publicar un comentario